ARS Pharmaceuticals, Inc.

SPRY ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G Mar 24, 2026
S-8 Mar 9, 2026 S-8
10-K Mar 9, 2026 10-K
8-K Mar 9, 2026 8-K
SCHEDULE 13G Feb 13, 2026
SCHEDULE 13G Jan 21, 2026
4 Jan 5, 2026
4 Jan 5, 2026
4 Jan 5, 2026
4 Jan 5, 2026
4 Jan 5, 2026
4 Jan 5, 2026
4 Jan 5, 2026
4 Nov 14, 2025
4 Nov 14, 2025
4 Nov 14, 2025
144 Nov 13, 2025
144 Nov 12, 2025
144/A Nov 12, 2025
144 Nov 12, 2025
10-Q Nov 10, 2025 10-Q
8-K Nov 10, 2025 8-K
SCHEDULE 13D/A Oct 1, 2025
8-K Sep 29, 2025 8-K
8-K Aug 28, 2025 8-K
← Newer Page 3 of 22 · 544 filings Older →